Immix Biopharma, Inc. (IMMX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Immix Biopharma, Inc. has halted the offering of its common stock shares under a previously dated prospectus supplement, in connection with a Sales Agreement with ThinkEquity LLC. The company has indicated that no new stock sales will occur until a new prospectus supplement is filed. Despite this pause, their Sales Agreement remains valid, emphasizing that this announcement is not an attempt to sell or solicit securities sales.
For further insights into IMMX stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.